The Merlin CP-GEP Test, validated in the largest prospective gene expression profiling study in melanoma ( MERLIN_001 ), demonstrated that a High-Risk result identifies patients with a threefold ...
Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...